157 related articles for article (PubMed ID: 38033504)
1. The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients.
Li L; Li Y; Lu M; Wang Y; Li Z; Hu X; He X; Gong T; Luo Y; Zhou Y; Min L; Tu C
Front Oncol; 2023; 13():1235158. PubMed ID: 38033504
[TBL] [Abstract][Full Text] [Related]
2. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
4. The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Dan J; Tan J; Huang J; Zhang X; Guo Y; Huang Y; Yang J
Breast Cancer; 2020 Sep; 27(5):982-988. PubMed ID: 32306184
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
6. High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
Rich NE; Parvathaneni A; Sen A; Odewole M; Arroyo A; Mufti AR; Kerr TA; Grant L; Tujios SR; Mayo MJ; Lee WM; Yang JD; Yokoo T; Gopal P; Hoshida Y; Zhu H; Yopp AC; Marrero JA; Singal AG
Dig Dis Sci; 2022 Jun; 67(6):2666-2676. PubMed ID: 33939138
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
8. Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio.
Kocak MZ; Coban S; Araz M; Eryilmaz MK; Artac M
Support Care Cancer; 2023 May; 31(6):357. PubMed ID: 37246994
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.
Yang S; Wu C; Wang L; Shan D; Chen B
Int J Clin Exp Pathol; 2020; 13(3):515-524. PubMed ID: 32269690
[TBL] [Abstract][Full Text] [Related]
11. Baseline and early changes in the neutrophil-lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy.
Ouyang H; Xiao B; Huang Y; Wang Z
Int Immunopharmacol; 2023 Oct; 123():110703. PubMed ID: 37536184
[TBL] [Abstract][Full Text] [Related]
12. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
14. Dynamic perioperative variation of neutrophil-to-lymphocyte ratio as an independent prognosis factor following lobectomy for NSCLC.
Micaela R; Lucas C; Franco C; Federico C; Agustín D; David S
Updates Surg; 2021 Aug; 73(4):1567-1574. PubMed ID: 33387167
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
16. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
Chen Z; Zhao G; Chen F; Xia J; Jiang L
BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
[TBL] [Abstract][Full Text] [Related]
18. Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study.
Tang H; Liu D; Lu J; He J; Ji S; Liao S; Wei Q; Lu S; Liu Y
BMC Cancer; 2022 Jan; 22(1):33. PubMed ID: 34983443
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative P-CRP in patients with osteosarcoma: A retrospective study of 101 cases.
Peng H; Fang X; Xu Y; Wei L; Qin Y; Yang F; Lu S; Zhao J
Medicine (Baltimore); 2022 Sep; 101(35):e30382. PubMed ID: 36107592
[TBL] [Abstract][Full Text] [Related]
20. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
